Showing results (961-970 of 1,047) with videos related to

Sort By:
Pageof 105
Drug Discoveries & Therapeutics|February 14, 2017
Cocoon carcinomatosa: An unusual cause of intestinal obstructionJimil Shah, Amit Kumar, Harjeet Singh, et al.
Drug Discoveries & Therapeutics|February 17, 2017
Decreased sugar concentration in vegetable and fruit juices by growth of functional lactic acid bacteriaMasaki Ishii, Yasuhiko Matsumoto, Satoshi Nishida, et al.
Drug Discoveries & Therapeutics|March 22, 2017
Comparison of three acute stress models for simulating the pathophysiology of stress-related mucosal diseaseBhagawati Saxena, Sanjay Singh
Drug Discoveries & Therapeutics|March 22, 2017
Levetiracetam and topiramate poisoning: Two overdoses on those drugs with no lasting effectsMoaziz Sarfaraz, Rana Hasan Syeda
Drug Discoveries & Therapeutics|September 20, 2019
Utility of an adverse drug event database based on the narrative accounts of patients with breast cancerKei Kikuchi, Akiko Miki, Hiroki Satoh, et al.
Drug Discoveries & Therapeutics|September 20, 2019
Cur2004-8, a synthetic curcumin derivative, extends lifespan and modulates age-related physiological changes in Caenorhabditis elegansBo-Kyoung Kim, Sung-A Kim, Sun-Mi Baek, et al.
Drug Discoveries & Therapeutics|September 20, 2019
Detection of Trichophyton spp. from footwear of patients with tinea pedisSanae A Ishijima, Masataro Hiruma, Kazuhisa Sekimizu, et al.
Drug Discoveries & Therapeutics|March 21, 2014
Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosisJinhua Chen, Wenfang Wang, Hongyuan Wang, et al.
Drug Discoveries & Therapeutics|March 21, 2014
Fibroblast growth factor-2 inhibits mineralization of osteoblast-like Saos-2 cells by inhibiting the functioning of matrix vesiclesChao Liu, Yazhou Cui, Jing Luan, et al.
Drug Discoveries & Therapeutics|March 21, 2014
A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: safety report of the UFT/LV studyAkio Saiura, Junji Yamamoto, Kiyoshi Hasegawa, et al.
Pageof 105